TOP 30 Clinical research in White Bear Lake, Minnesota

4 results found

MicroBio Consulting, located in Chisago City, Minnesota, is a leading health institution dedicated to providing elite consulting services in compliance with your budget and timeline. Our experts offer virtual trainings, shareable knowledge, gap assessments, and more to support the development of science, scientists, and medical technology. We specialize in microbiological investigations and testing, ensuring that your products and manufacturing processes meet sterility requirements. Our services also focus on maintaining product safety and efficacy, evaluating product and material compatibility, understanding chemical profiles, and assessing toxicological risks. Contact us at [email protected] or visit our office in White Bear Lake for cutting-edge solutions in the medical industry.

The Betsy Dickson healthcare institution, located at 1430 Highway 96 East in White Bear Lake, Minnesota, is dedicated to providing high-quality medical care to patients in the area. Our team of experienced doctors and healthcare professionals are committed to ensuring the well-being and health of our patients. Whether you need a routine check-up or specialized medical treatment, Betsy Dickson is here to provide compassionate and personalized care. Visit us today to experience the difference our institution can make in your health and wellness journey.

Lauren Robbins is a health institution located at 2025 4th Street in White Bear Lake, Minnesota, United States. This facility provides a range of healthcare services to residents in the area, including medical consultations, screenings, and treatments. With a team of dedicated healthcare professionals, Lauren Robbins is committed to promoting the well-being and health of its patients. Whether you are in need of routine check-ups or specialized medical care, this institution is here to serve your healthcare needs.

IGF Oncology, located at 429 Birchwood Courts in White Bear Lake, Minnesota, is a pioneering institution focused on developing innovative cancer drugs with improved efficacy and reduced side effects compared to traditional chemotherapy treatments. Their lead drug, IGF-MTX, has shown to be 15 times more effective than methotrexate in animal studies, with significantly lower side effects. This drug has completed a Phase 1 study in advanced solid tumors, demonstrating effectiveness even in heavily pre-treated patients. IGF-MTX is currently in a clinical trial at the Mayo Clinic for myelodysplastic syndrome, with promising early results. In addition to their lead drug, IGF Oncology has a pipeline of targeted cancer drugs in development. Registered in Delaware, IGF Oncology, LLC is a cutting-edge institution at the forefront of cancer research and treatment.